Cooler Heads
Private Company
Total funding raised: $35M
Overview
Cooler Heads, founded in 2018 and based in San Diego, is a commercial-stage medical device company addressing a significant unmet need in oncology supportive care. Its flagship product, the Amma™ Scalp Cooling System, is an FDA-cleared, portable device that helps adult patients with solid tumors preserve their hair during chemotherapy by cooling the scalp. The company operates by making Amma available through infusion centers upon provider prescription, with a dedicated customer care team supporting patients and clinics. Cooler Heads is positioned in the growing market for oncology supportive care devices, competing with other cold cap providers by emphasizing portability and a simplified, patient-friendly design.
Technology Platform
Portable scalp cooling system consisting of a custom-fitted cooling wrap, neoprene strap, compression cap, and a portable cooling unit that circulates chilled fluid to constrict blood vessels in the scalp and protect hair follicles during chemotherapy.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Cooler Heads competes in the scalp cooling market against established players like Paxman (global leader) and DigniCap (owned by Swedish company Dignitana). Competition is based on device efficacy, patient comfort, portability, cost, and the level of support provided to clinics. Cooler Heads' key differentiator is the portability of the Amma system, allowing patient mobility post-infusion, and its emphasis on a simplified, patient-first design and support model.